Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1992 Mar;19(1):179-95.

Nephrocalcinosis

Affiliations
  • PMID: 1576767
Review

Nephrocalcinosis

N D Adams et al. Clin Perinatol. 1992 Mar.

Abstract

The pathogenesis of NC in VLBW infants appears to be multifactorial. The vulnerability of extreme immaturity and the underdevelopment of renal function may be the most important variables. In some ways, we view this problem as similar to that of retinopathy of prematurity. (Clearly the exposure of the retina to high partial pressures of oxygen contributes to the development of retinopathy of prematurity but other variables--some known, such as an immature retina, and others not yet defined--must be present.) Hypercalciuria is common in the VLBW infant, yet not all develop NC. Decreased glomerular filtration rate, low citrate excretion, and frequently an alkaline urine are in part due to the immaturity of renal function of these infants. The need for prolonged hyperalimentation resulting in increased oxalate excretion and the development of BPD frequently requiring diuretics that may cause phosphaturia and magnesium depletion and that may increase calcium excretion are more common in the smallest and sickest of premature infants. Even transient insults to the kidneys, such as hypoxia or hypotension or the use of nephrotoxic drugs that provoke tubular injury and cell death with the probability of crystal formation and growth by way of heterogeneous nucleation, are likely to occur more frequently in this vulnerable population.

PubMed Disclaimer

Similar articles

Cited by

  • Does citrate prevent nephrocalcinosis in preterm neonates?
    Schell-Feith EA, Moerdijk A, van Zwieten PH, Zonderland HM, Holscher HC, Kist-van Holthe J, van der Heijden BJ. Schell-Feith EA, et al. Pediatr Nephrol. 2006 Dec;21(12):1830-6. doi: 10.1007/s00467-006-0274-4. Epub 2006 Oct 13. Pediatr Nephrol. 2006. PMID: 17039333 Clinical Trial.
  • Drug-Induced Urolithiasis in Pediatric Patients.
    Sighinolfi MC, Eissa A, Bevilacqua L, Zoeir A, Ciarlariello S, Morini E, Puliatti S, Durante V, Ceccarelli PL, Micali S, Bianchi G, Rocco B. Sighinolfi MC, et al. Paediatr Drugs. 2019 Oct;21(5):323-344. doi: 10.1007/s40272-019-00355-5. Paediatr Drugs. 2019. PMID: 31541411 Review.
  • Clinical pharmacology of furosemide in neonates: a review.
    Pacifici GM. Pacifici GM. Pharmaceuticals (Basel). 2013 Sep 5;6(9):1094-129. doi: 10.3390/ph6091094. Pharmaceuticals (Basel). 2013. PMID: 24276421 Free PMC article.
  • Nephrocalcinosis in preterm babies.
    Narendra A, White MP, Rolton HA, Alloub ZI, Wilkinson G, McColl JH, Beattie J. Narendra A, et al. Arch Dis Child Fetal Neonatal Ed. 2001 Nov;85(3):F207-13. doi: 10.1136/fn.85.3.f207. Arch Dis Child Fetal Neonatal Ed. 2001. PMID: 11668166 Free PMC article.
  • An infant with hypercalcemia: answers.
    Guarino S, Marzuillo P, Apicella A, Annicchiarico Petruzzelli L, La Manna A. Guarino S, et al. Pediatr Nephrol. 2014 Nov;29(11):2123-5. doi: 10.1007/s00467-013-2639-9. Epub 2013 Oct 19. Pediatr Nephrol. 2014. PMID: 24141525 No abstract available.

Publication types

LinkOut - more resources